分数阶微积分扩散模型预测外周带前列腺癌侵袭性
该回顾性研究纳入75例MRI引导穿刺活检的前列腺癌患者,评估FROC模型参数D、β、μ在鉴别外周带前列腺癌分级中的价值。结果显示,D与β联合在鉴别低危与中危组时AUC为0.829,优于ADC的0.655;D、β、μ联合在鉴别临床显著与否时AUC为0.802,优于ADC的0.671。FROC模型有望成为无创评估外周带前列腺癌的定量影像技术。
要点
- FROC参数联合诊断效能优于ADC,尤其鉴别低危与中危前列腺癌。
- D与β联合鉴别GS6与GS7的AUC为0.829。
- D、β、μ联合鉴别临床显著癌的AUC为0.802。
核心结论
- FROC参数联合在鉴别低危与中危、临床显著与不显著外周带前列腺癌方面优于ADC。
研究设计与样本
- 回顾性研究,纳入75例在MRI后6个月内接受靶向MRI引导经直肠超声前列腺活检的患者。
- 在MRI可疑病灶上放置感兴趣区,并根据穿刺位置与病理结果关联。
- 最终肿瘤计数:GS6(3+3)23个,GS7(3+4)36个,GS7(4+3)18个,GS≥8 19个。
- 扩散加权成像分别拟合FROC模型和单指数模型,计算ADC及FROC参数D、β、μ。
- 采用ROC分析评估FROC参数与ADC鉴别前列腺癌分级的效能。
诊断标准与关键数值
- 鉴别低危(GS6)与中危(GS7)外周带前列腺癌时,D与β联合AUC为0.829,显著优于ADC的AUC 0.655(p=0.018)。
- 鉴别临床显著(GS≥7)与不显著(GS6)前列腺癌时,D、β、μ联合AUC最高为0.802,显著优于ADC的AUC 0.671(p=0.038)。
- FROC参数在区分中危(GS7)与高危(GS≥8)前列腺癌时与ADC相比未达到显著差异。
临床应用与阅片要点
- 在外周带前列腺癌MRI评估中,可尝试利用FROC模型参数联合提高分级诊断信心。
- FROC参数联合有助于鉴别低危与中危前列腺癌,辅助临床决策。
局限性
- 回顾性研究设计。
- 样本量较小(75例)。
- 单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the performance of parameters D, β, μ from the Fractional Order Calculus (FROC) model at differentiating peripheral zone (PZ) prostate cancer (PCa) MATERIAL AND METHODS: 75 patients who underwent targeted MRI-guided TRUS prostate biopsy within 6 months of MRI were reviewed retrospectively. Regions of interest (ROI) were placed on suspicious lesions on MRI scans. ROIs were then correlated to pathological results based on core biopsy location. The final tumor count is a total: 23 of GS 6 (3 + 3), 36 of GS 7 (3 + 4), 18 of GS 7 (4 + 3), and 19 of GS ≥ 8. Diffusion-weighted imaging (DWI) scans were fitted into the FROC and monoexponential model to calculate ADC and FROC parameters: anomalous diffusion coefficient D, intravoxel diffusion heterogeneity β, and spatial parameter μ. The performance of FROC parameters and ADC at differentiating PCa grade was evaluated with receiver operating characteristic (ROC) analysis.
RESULTS: In differentiating low (GS 6) vs. intermediate (GS 7) risk PZ PCa, combination of (D, β) provides the best performance with AUC of 0.829 with significance of p = 0.018 when compared to ADC (AUC of 0.655). In differentiating clinically significant (GS 6) vs. clinically significant (GS ≥ 7) PCa, combination of (D, β, μ) provides highest AUC of 0.802 when compared to ADC (AUC of 0.671) with significance of p = 0.038. Stratification of intermediate (GS 7) and high (GS ≥ 8) risk PCa with FROC did not reach a significant difference when compared to ADC.
CONCLUSION: Combination of FROC parameters shows greater performance than ADC at differentiating low vs. intermediate risk and clinically insignificant vs. significant prostate cancers in peripheral zone lesions. The FROC diffusion model holds promise as a quantitative imaging technique for non-invasive evaluation of PZ PCa.
引用
- Li Z, Dan G, Tammana V, et al. Predicting the aggressiveness of peripheral zone prostate cancer using a fractional order calculus diffusion model. Eur J Radiol. 2021. PMID: 34464907. doi:10.1016/j.ejrad.2021.109913
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。